Complete Story


How to Get RSV Vaccines to Those Who Need Them Most

These shots are welcome since RSV can be deadly in the very old and very young

The world is entering a new era of vaccines. Following the success of COVID-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus' structure, putting a host of new vaccines on the horizon.

The most recent arrivals are several new immunizations against respiratory syncytial virus, or RSV.

These shots are welcome since RSV can be dangerous, even deadly, in the very old and very young. But the shots, produced by Pfizer and GlaxoSmithKline, are also expensive, costing about $300 for those directed at adults, and up to $1,000 for one of the shots, a monoclonal antibody rather than a traditional vaccine, intended for babies. Many older vaccines cost pennies.

Please select this link to read the complete article from TIME.

Printer-Friendly Version